Repository logo
 
Publication

Extraction Optimization and Structural and Thermal Characterization of the Antimicrobial Abietane 7α-Acetoxy-6βhydroxyroyleanone

dc.contributor.authorBernardes, C.
dc.contributor.authorGarcia, C.
dc.contributor.authorPereira, F.
dc.contributor.authorMota, J.
dc.contributor.authorPereira, P.
dc.contributor.authorCebola, M.J.
dc.contributor.authorReis, C.
dc.contributor.authorCorreia, I.
dc.contributor.authorPiedade, M.F.
dc.contributor.authorPiedade, M.
dc.date.accessioned2025-02-07T16:20:07Z
dc.date.available2025-02-07T16:20:07Z
dc.date.issued2018-04
dc.description.abstractThe abietane 7α-acetoxy-6β-hydroxyroyleanone (AHR), obtained from plant extracts, is an attractive lead for drug development, given its known antimicrobial properties. Two basic requirements to establish any compound as a new drug are the development of a convenient extraction process and the characterization of its structural and thermal properties. In this work seven different methods were tested to optimize the extraction of AHR from Plectranthus grandidentatus. Supercritical fluid extraction (SFE) proved to be the method of choice, delivering an amount of AHR (57.351 μg·mg-1) approximately six times higher than the second best method (maceration in acetone; 9.77 μg·mg-1). Single crystal X-ray diffraction analysis of the ARH molecular and crystal structure carried out at 167 ± 2 K and 296 ± 2 K showed only a single phase, here dubbed form III (orthorhombic space group P21212), at those temperatures. The presence of two other polymorphs above room temperature was, however, evidenced by differential scanning calorimetry (DSC). The three forms are enantiotropically related, with the form III → form II and form II → form I transitions occurring at 333.5 ± 1.6 K and 352.0 ± 1.6 K, respectively. The fact that the transitions are reversible suggests that polymorphism is not likely to be an issue in the development pharmaceutical formulations based on ARH. DSC experiments also showed that the compound decomposes on melting at 500.8 ± 0.8 K. Melting should therefore be avoided if, for example, strategies to improve solubility based on the production of glassy materials or solid dispersions are considered.pt_PT
dc.description.versioninfo:eu-repo/semantics/publishedVersionpt_PT
dc.identifier.citationBernardes CES, Garcia C, Pereira F, Mota J, Pereira P, Cebola MJ, Reis CP, Correia I, Piedade MFM, Minas da Piedade ME, Rijo P. Extraction Optimization and Structural and Thermal Characterization of the Antimicrobial Abietane 7α-Acetoxy-6β-hydroxyroyleanone. Mol Pharm. 2018 Apr 2;15(4):1412-1419.pt_PT
dc.identifier.doihttps://doi.org/10.1021/acs.molpharmaceut.7b00892pt_PT
dc.identifier.urihttp://hdl.handle.net/10400.26/54318
dc.language.isoengpt_PT
dc.titleExtraction Optimization and Structural and Thermal Characterization of the Antimicrobial Abietane 7α-Acetoxy-6βhydroxyroyleanonept_PT
dc.typejournal article
dspace.entity.typePublication
oaire.citation.endPage1419pt_PT
oaire.citation.issue4pt_PT
oaire.citation.startPage1412pt_PT
oaire.citation.titleMolecular Pharmaceuticspt_PT
oaire.citation.volume15pt_PT
rcaap.rightsclosedAccesspt_PT
rcaap.typearticlept_PT

Files

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
Extraction Optimization and Structural and Thermal Characterization of the Antimicrobial Abietane 7α-Acetoxy-6βhydroxyroyleanone.pdf
Size:
785.41 KB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.85 KB
Format:
Item-specific license agreed upon to submission
Description: